Sponsor pipeline

Immedica Pharma AB clinical trial pipeline

Get alerts when Immedica Pharma AB's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT05249556 Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency… CDKL5 Deficiency Disorder Not Yet Recruiting 2026-08-05
Get alerts when Immedica Pharma AB's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free